» Articles » PMID: 29774483

Analysis of Unexplained Carcinoembryonic Antigen Elevation After Curative Treatment of Locally Advanced Rectal Cancer

Overview
Specialty Oncology
Date 2018 May 19
PMID 29774483
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To analyze the causes and patterns of unexplained carcinoembryonic antigen (CEA) elevation after curative treatment in locally advanced rectal cancer patients.

Methods: Among the 1309 locally advanced rectal cancer patients treated with curative resection and radiotherapy between January 2001 and June 2011, 325 patients who postoperatively developed abnormal CEA elevation were reviewed. The unexplained CEA elevation was defined as a CEA level higher than 5 ng/mL with no evidence of cancer recurrence at the time of elevation.

Results: Of the 325 patients, 143 (44%) had unexplained CEA elevations. The causes were categorized as delayed recurrence (n = 29, 20%), non-colorectal malignancy (n = 10, 7%), and non-malignancy-related conditions (n = 104, 73%). Shorter intervals between treatment and the first CEA elevation, and a higher peak CEA level, were observed in the delayed recurrence group compared with the non-colorectal malignancy or non-malignancy-related group (intervals of 6.8 vs. 44.9 vs. 23.2 months, respectively, p = 0.002; and peak CEA levels of 9.9 vs. 7.1 vs. 6.2 ng/mL, respectively, p = 0.034). In patients who showed delayed recurrence, the interval between the first CEA elevation and diagnosis of recurrence was a median of 13.0 months (range 3.8-60.6 months). Smoking was the most common cause for non-malignancy-related conditions. The patterns of unexplained CEA elevations were defined as sporadic (n = 78, 55%), stationary (n = 37, 26%), and increasing (n = 28, 20%). The patterns were significantly different depending on the cause (p < 0.001).

Conclusions: Analysis of the patterns of unexplained CEA elevations is a reasonable approach to predict the cause of the cancer.

Citing Articles

Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review.

Kheirouri S, Alizadeh M Adv Nutr. 2020; 12(1):234-250.

PMID: 32910812 PMC: 7850023. DOI: 10.1093/advances/nmaa102.

References
1.
MOERTEL C, Fleming T, Macdonald J, Haller D, Laurie J, Tangen C . An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993; 270(8):943-7. View

2.
Stockley R, Shaw J, WHITFIELD A, Whitehead T, Clarke C, Burnett D . Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions. Thorax. 1986; 41(1):17-24. PMC: 460246. DOI: 10.1136/thx.41.1.17. View

3.
Gold P, Freedman S . DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965; 121:439-62. PMC: 2137957. DOI: 10.1084/jem.121.3.439. View

4.
Park S, Kim J . Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J. 2016; 34(2):96-105. PMC: 4938351. DOI: 10.3857/roj.2016.01704. View

5.
Duffy M, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R . Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007; 43(9):1348-60. DOI: 10.1016/j.ejca.2007.03.021. View